RxDoctor Payments DataLook up a doctor →

Kimberly Woods

Family · Statesville, NCNPI 1912427659

Payments from drug & device makers

$61,948in general payments, 2019–2025

Across 1,170 payments — averaging $52.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$28K
  • AbbVie$15K
  • Inspire Medical Systems, Inc.$2K
  • UCB, Inc.$1K
  • SK Life Science, Inc.$1K
  • Pfizer$1K
  • plus $13K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC92$27,921
AbbVie(2 entities)156$15,483
Inspire Medical Systems, Inc.29$1,782
UCB, Inc.71$1,344
SK Life Science, Inc.55$1,216
Pfizer39$1,070
Teva Pharmaceuticals USA, Inc.66$1,023
Jazz Pharmaceuticals Inc.39$983
MDD US Operations, LLC69$938
Neurelis, Inc.48$899
Acadia Pharmaceuticals Inc31$762
Biogen45$736
Neurocrine Biosciences, Inc.48$695
Axsome Therapeutics, Inc.25$587
Amgen29$537
Eisai Inc.31$530
Lundbeck LLC18$431
Sunovion Pharmaceuticals Inc.27$403
Novartis22$398
Scilex Pharmaceuticals Inc.15$309
Argenx US, Inc.12$297
Sumitomo Pharma America, Inc.12$253
Harmony Biosciences LLC9$237
Upsher-smith Laboratories LLC15$230
Amneal Pharmaceuticals LLC18$229
Sanofi10$220
Aucta Pharmaceuticals, Inc.12$216
Idorsia Pharmaceuticals US Inc15$197
Biohaven Pharmaceutical Holding Company Ltd.14$170
Azurity Pharmaceuticals, Inc.6$153
AstraZeneca(2 entities)8$150
Otsuka America Pharmaceutical, Inc.6$149
Biohaven Pharmaceuticals, Inc.14$141
Avadel CNS Pharmaceuticals, LLC4$107
Impel Pharmaceuticals LLC4$102
Collegium Pharmaceutical, Inc.6$95
Impel Pharmaceuticals Inc.5$95
Almatica Pharma LLC6$93
Boston Scientific3$87
Acorda Therapeutics, Inc5$69
CSL Behring3$63
Supernus Pharmaceuticals, Inc.3$57
Arbor Pharmaceuticals, Inc.3$53
Grifols USA, LLC2$50
ANI Pharmaceuticals, Inc.2$48
Corium, LLC2$40
Mallinckrodt Hospital Products Inc.2$40
Octapharma USA, Inc.1$30
Takeda Pharmaceuticals U.S.A., Inc.1$27
Avanir Pharmaceuticals, Inc.1$22
Insightec,inc1$22
Inogen, Inc.2$22
3b Medical, Inc.1$21
Otsuka Pharmaceutical Development & Commercialization, Inc.1$20
Avion Pharmaceuticals1$19
Sanofi-aventis U.S. LLC1$17
Novo Nordisk1$16
GE HealthCare1$15
Medtronic1$14
Aprecia Pharmaceuticals, LLC1$14

How this compares

$61,948 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina →

Medicare billing

Part B allowed, 2024
$26,481
Medicare patients
204
Services billed
389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Statesville

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →